Arbutus Biopharma Corporation
Patents = 56
Trademarks = 4
Forward Citations = 331
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
210 inventors (with patents filed for the assignee):
Arbutus Biopharma Corporation is a publicly traded biopharmaceutical company dedicated to discovering, developing, and commercializing a cure for patients suffering from chronic hepatitis B virus (HBV) infection. With an experienced team and a strong pipeline of innovative therapeutic candidates, Arbutus aims to transform the lives of millions affected by this devastating disease. The company's research focuses on advancing a range of drug candidates, including RNA interference (RNAi) -based therapeutics, gene editing technologies, and combination therapies.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com